Product Information

PREGABALIN 300 MG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0690 per EA under NDC 31722061705. Its NADAC has been published 204 times since Dec 21, 2022.

FDA first approved this application on Oct 8, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 300 MG CAPSULE

Pregabalin
$0.0690per EA
DEA Schedule CV

Strength

300 mg/1

NDC

31722061705

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA206912

FDA Approved

10/8/2019

TE Code

AB

On Market Since

10/8/2019

Price Statistics

The NADAC for PREGABALIN 300 MG CAPSULE has been published 204 times since Dec 21, 2022, and over the history we have for it it has declined 29.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0690 per EA
All-time high$0.1078 (Jun 14, 2023)
All-time low$0.0628 (Nov 20, 2024)
52-week high$0.0698
52-week low$0.0644
Median price$0.0800
Average price$0.0807
Largest weekly change+30.8% (Aug 21, 2024)
Weeks tracked204
Tracking sinceDec 21, 2022

Price History

1W

0.0%

1M

+3.7%

3M

+6.9%

6M

+5.7%

1Y

-3.3%

3Y

-23.9%

5Y

N/A

All

-29.9%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of PREGABALIN 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.0690 per EA (NDC 31722061705), effective Nov 11, 2026.

How has the price of PREGABALIN 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has declined 29.9%. It has been tracked across 204 weekly CMS publications since Dec 21, 2022.

What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?

Since Dec 21, 2022, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0628 (Nov 20, 2024) to a high of $0.1078 (Jun 14, 2023), with a median of $0.0800 per EA.

Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?

Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PREGABALIN 300 MG CAPSULE, is $0.0669 per EA — about 3% below PREGABALIN 300 MG CAPSULE.

Who manufactures PREGABALIN 300 MG CAPSULE?

PREGABALIN 300 MG CAPSULE (NDC 31722061705) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.